Cargando…
Beat the giant: case of a giant prolactinoma during pregnancy on cabergoline
Giant prolactinomas are a rare entity; during pregnancy, the risk for complications associated with these tumors is higher. Here, we report a case of a young woman who had an invasive, giant prolactinoma post resection with residual disease who became pregnant. This patient was treated with cabergol...
Autores principales: | Almistehi, Wael M, Almalki, Mussa H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109208/ https://www.ncbi.nlm.nih.gov/pubmed/30159146 http://dx.doi.org/10.1530/EDM-18-0099 |
Ejemplares similares
-
Cabergoline reduces 3-methoxytyramine in a SDHC patient with metastatic paraganglioma and prolactinoma
por: Hussein, Ziad, et al.
Publicado: (2021) -
Cabergoline Treatment in Invasive Giant Prolactinoma
por: Alsubaie, Sadeem, et al.
Publicado: (2014) -
A macroprolactinoma becoming resistant to cabergoline and developing
atypical pathology
por: Sbardella, Emilia, et al.
Publicado: (2016) -
Abstract 94: Efficacy of cabergoline treatment in men with giant prolactinomas
Publicado: (2022) -
Efficacy and Safety of Cabergoline as First Line Treatment for Invasive Giant Prolactinoma
por: Cho, Eun-Hee, et al.
Publicado: (2009)